Prescription Drug Affordability Boards Reshape Reimbursement While Leaving Core Problems Unresolved William V. Padula October 15, 2026

https://www.healthaffairs.org/content/forefront/prescription-drug-affordability-boards-reshape-reimbursement-while-leaving-core?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-8eaReOfyM41Pfd2z6bisiJtjOHsrBvrLbC65_1vZpi8vlGoVh6nuY9eM0Z2wVebLuAd3svDO8RqYnOUkl-GFpYlI8mgQ&_hsmi=444676880&utm_source=hasu State boards were established to address legitimate concerns about prescription drug costs and patient affordability, but don’t use the right measures to assess what patients actually pay.